loadpatents
name:-0.34948492050171
name:-0.011742830276489
name:-0.14544105529785
Sampei; Zenjiro Patent Filings

Sampei; Zenjiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sampei; Zenjiro.The latest application filed is for "multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii".

Company Profile
14.8.30
  • Sampei; Zenjiro - Shizuoka JP
  • SAMPEI; Zenjiro - Gotemba-shi JP
  • SAMPEI; Zenjiro - Shizuoka Pref. Gotemba City
  • Sampei; Zenjiro - Singapore SG
  • Sampei; Zenjiro - Synapse SG
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Multi-specific Antigen-binding Molecule Having Alternative Function To Function Of Blood Coagulation Factor Viii
App 20220267470 - Igawa; Tomoyuki ;   et al.
2022-08-25
Information Processing System, Information Processing Method, Program, And Method For Producing Antigen-binding Molecule Or Protein
App 20220253669 - TERAMOTO; Reiji ;   et al.
2022-08-11
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20220135618 - Igawa; Tomoyuki ;   et al.
2022-05-05
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20210292360 - Igawa; Tomoyuki ;   et al.
2021-09-23
Anti-dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20210095008 - SAMPEI; Zenjiro ;   et al.
2021-04-01
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20210040147 - Igawa; Tomoyuki ;   et al.
2021-02-11
Anti-dengue Virus Antibodies Having Cross-reactivity To Zika Virus And Methods Of Use
App 20210017256 - FINK; Katja ;   et al.
2021-01-21
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventing A C5-related Disease
App 20200407432 - SHINOMIYA; Kenji ;   et al.
2020-12-31
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,844,113 - Sampei , et al. November 24, 2
2020-11-24
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20200207805 - Igawa; Tomoyuki ;   et al.
2020-07-02
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,604,561 - Sampei , et al.
2020-03-31
Anti-c5 Antibodies And Methods Of Use
App 20200031913 - RUIKE; Yoshinao ;   et al.
2020-01-30
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventin
App 20190367599 - SHINOMIYA; Kenji ;   et al.
2019-12-05
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20190352334 - Igawa; Tomoyuki ;   et al.
2019-11-21
Anti-sclerostin Antibodies And Methods Of Use
App 20190352387 - SAMPEI; Zenjiro
2019-11-21
Methods of treatment that include the administration of bispecific antibodies
Grant 10,450,381 - Igawa , et al. Oc
2019-10-22
Multi-specific Antigen-binding Molecule Having Alternative Function To Function Of Blood Coagulation Factor Viii
App 20190315884 - Igawa; Tomoyuki ;   et al.
2019-10-17
Anti-dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20190315840 - SAMPEI; Zenjiro ;   et al.
2019-10-17
Nucleic acids encoding anti-C5 antibodies
Grant 10,385,122 - Ruike , et al. A
2019-08-20
Anti-dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20190218277 - SAMPEI; Zenjiro ;   et al.
2019-07-18
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20190062368 - Igawa; Tomoyuki ;   et al.
2019-02-28
Anti-c5 Antibodies And Methods Of Use
App 20190062413 - RUIKE; Yoshinao ;   et al.
2019-02-28
Methods of neutralizing C5 with anti-C5 antibodies
Grant 10,023,630 - Ruike , et al. July 17, 2
2018-07-17
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20180162902 - Igawa; Tomoyuki ;   et al.
2018-06-14
Anti-c5 Antibodies And Methods Of Use
App 20180002415 - RUIKE; Yoshinao ;   et al.
2018-01-04
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20170275332 - Igawa; Tomoyuki ;   et al.
2017-09-28
Anti-C5 antibodies
Grant 9,765,135 - Ruike , et al. September 19, 2
2017-09-19
Nucleic Acid Encoding Bispecific Antibodies
App 20170022293 - Igawa; Tomoyuki ;   et al.
2017-01-26
Multi-specific Antigen-binding Molecule Having Alternative Function To Function Of Blood Coagulation Factor Viii
App 20160222129 - Igawa; Tomoyuki ;   et al.
2016-08-04
Anti-C5 Antibodies and Methods of Use
App 20160176954 - RUIKE; Yoshinao ;   et al.
2016-06-23
Bispecific antibodies
Grant 9,334,331 - Igawa , et al. May 10, 2
2016-05-10
Multi-specific Antigen-binding Molecules And Uses Thereof
App 20140370018 - Igawa; Tomoyuki ;   et al.
2014-12-18
Multi-specific Antigen-binding Molecules And Uses Thereof
App 20140037632 - Igawa; Tomoyuki ;   et al.
2014-02-06
Multi-specific Antigen-binding Molecule Having Alternative Function To Function Of Blood Coagulation Factor Viii
App 20130330345 - Igawa; Tomoyuki ;   et al.
2013-12-12
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20130018174 - Igawa; Tomoyuki ;   et al.
2013-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed